Allurion Technologies (NYSE:ALUR) Posts Earnings Results

Allurion Technologies (NYSE:ALUR) announced its earnings results on Tuesday. The company reported $0.11 earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $9.39 million during the quarter. Allurion Technologies updated its FY 2024 guidance to EPS.

Allurion Technologies Stock Down 2.7 %

Shares of NYSE:ALUR traded down $0.05 on Friday, reaching $1.81. 17,160 shares of the company traded hands, compared to its average volume of 681,845. Allurion Technologies has a 52 week low of $1.56 and a 52 week high of $9.00. The business’s 50-day simple moving average is $2.15 and its 200 day simple moving average is $3.01.

Wall Street Analysts Forecast Growth

ALUR has been the subject of a number of research reports. Chardan Capital reiterated a “buy” rating and issued a $5.00 price objective on shares of Allurion Technologies in a report on Wednesday. Jefferies Financial Group initiated coverage on shares of Allurion Technologies in a research note on Friday, February 9th. They set a “buy” rating and a $5.00 price target on the stock.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.